Ellen's most recent trade in Ameren Corp. was a trade of 1,686 Common Stock, $.01 Par Value done . Disclosure was reported to the exchange on Jan. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ameren | Ellen M. Fitzsimmons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 1,686 | 53,026 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Compass Therapeutics Inc | Ellen V. Chiniara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.27 per share. | 02 Jan 2026 | 29,683 | 464,601 (0%) | 0% | 14.3 | 423,576 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.27 per share. | 02 Jan 2026 | 13,426 | 494,284 (0%) | 0% | 14.3 | 191,589 | Common Stock |
| Norwegian Cruise Line | Zillah Ellen Byng-Thorne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 8,779 | 74,796 (0%) | 0% | 0 | Common Stock | |
| UDR | Ellen M. Goitia | Director | Grant, award, or other acquisition of securities at price $ 36.69 per share. | 02 Jan 2026 | 5,451 | 5,451 (0%) | 0% | 36.7 | 199,997 | Common Stock |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 3,731 | 3,731 | - | - | Restricted Stock Units | |
| WEC Energy | Mary Ellen Stanek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 1,749 | 52,442 | - | - | Phantom Stock Units | |
| WEC Energy | Mary Ellen Stanek | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Jan 2026 | 1,749 | 4,204 (0%) | 0% | - | Common Stock | |
| WEC Energy | Mary Ellen Stanek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 1,603 | 5,953 (0%) | 0% | 0 | Common Stock | |
| Citigroup | Ellen M. Costello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 1,262 | 1,262 (0%) | 0% | 0 | Common Stock | |
| Take-Two Interactive Software | Ellen F. Siminoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 96 | 8,351 (0%) | 0% | 0 | Common Stock | |
| NextPlat Corp | Douglas S. Ellenoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 21,176 | 166,176 (137%) | 17% | 0 | Common Stock | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 29.78 per share. | 31 Dec 2025 | 777 | 38,305 (0%) | 0% | 29.8 | 23,139 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 83.43 per share. | 31 Dec 2025 | 660 | 30,529 (0%) | 0% | 83.4 | 55,064 | Common Stock |
| Merck & Company | Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 285 | 29,231 | - | - | Phantom Stock | |
| Hyperion DeFi Inc | Ellen R. Strahlman | Director | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 26 Dec 2025 | 12,112 | 91,161 (0%) | 0% | 3.6 | 43,603 | Common Stock, par value $.0001 |
| Hyperion DeFi Inc | Ellen R. Strahlman | Director | Purchase of securities on an exchange or from another person at price $ 3.61 per share. | 26 Dec 2025 | 11,856 | 34,869 (0%) | 0% | 3.6 | 42,800 | Common Stock, par value $.0001 |
| Hyperion DeFi Inc | Ellen R. Strahlman | Director | Purchase of securities on an exchange or from another person at price $ 3.86 per share. | 26 Dec 2025 | 3,601 | 79,049 (0%) | 0% | 3.9 | 13,911 | Common Stock, par value $.0001 |
| Hyperion DeFi Inc | Ellen R. Strahlman | Director | Purchase of securities on an exchange or from another person at price $ 3.86 per share. | 26 Dec 2025 | 3,311 | 23,013 (0%) | 0% | 3.9 | 12,777 | Common Stock, par value $.0001 |
| Kroger | Mary Ellen Adcock | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.41 per share. | 19 Dec 2025 | 722 | 183,095 (0%) | 0% | 62.4 | 45,060 | Common Stock |
| Hyperion DeFi Inc | Ellen R. Strahlman | Director | Purchase of securities on an exchange or from another person at price $ 3.14 per share. | 18 Dec 2025 | 19,702 | 95,150 (0%) | 0% | 3.1 | 61,835 | Common Stock, par value $.0001 |
| Hyperion DeFi Inc | Ellen R. Strahlman | Director | Purchase of securities on an exchange or from another person at price $ 3.14 per share. | 18 Dec 2025 | 18,742 | 75,448 (0%) | 0% | 3.1 | 58,829 | Common Stock, par value $.0001 |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 80,745 | 1,381,484 | - | - | Stock Option (Right to Buy) | |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Sale of securities on an exchange or to another person at price $ 6.91 per share. | 15 Dec 2025 | 80,745 | 2,083,961 | - | 6.9 | 557,948 | Class A Common Stock |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 15 Dec 2025 | 80,745 | 2,164,706 | - | 0.2 | 19,379 | Class A Common Stock |
| Elme Communities | Ellen M. Goitia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 2,883 | 47,850 (0%) | 0% | 0 | Common Stock | |
| Oil-Dri Corp Of America | Ellen-Blair Chube | Director | Grant, award, or other acquisition of securities at price $ 51.68 per share. | 15 Dec 2025 | 1,000 | 10,320 (0%) | 0% | 51.7 | 51,680 | Common Stock |
| Valmont Ind Inc | Ellen S. Dasher | VP, Global Taxation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 534 | 534 | - | - | Non-Qualified Stock Option (right to buy) | |
| Take-Two Interactive Software | Ellen F. Siminoff | Director | Sale of securities on an exchange or to another person at price $ 242.71 per share. | 15 Dec 2025 | 270 | 3,080 (0%) | 0% | 242.7 | 65,532 | Common Stock |
| Valmont Ind Inc | Ellen S. Dasher | VP, Global Taxation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 173 | 6,559 (0%) | 0% | 0 | Common Stock | |
| Take-Two Interactive Software | Ellen F. Siminoff | Director | Sale of securities on an exchange or to another person at price $ 242.71 per share. | 15 Dec 2025 | 143 | 2,573 (0%) | 0% | 242.7 | 34,708 | Common Stock |
| Valmont Ind Inc | Ellen S. Dasher | VP, Global Taxation | Payment of exercise price or tax liability using portion of securities received from the company at price $ 410.65 per share. | 15 Dec 2025 | 31 | 6,528 (0%) | 0% | 410.6 | 12,730 | Common Stock |
| Valmont Ind Inc | Ellen S. Dasher | VP, Global Taxation | Payment of exercise price or tax liability using portion of securities received from the company at price $ 427.27 per share. | 11 Dec 2025 | 45 | 6,428 (0%) | 0% | 427.3 | 19,227 | Common Stock |
| Valmont Ind Inc | Ellen S. Dasher | VP, Global Taxation | Payment of exercise price or tax liability using portion of securities received from the company at price $ 417.55 per share. | 11 Dec 2025 | 42 | 6,386 (0%) | 0% | 417.5 | 17,537 | Common Stock |
| Aspira Women`s Health Inc | Ellen Beausang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2025 | 198,097 | 198,097 | - | - | Stock Option (Right to Buy) | |
| Interpublic Group | Ellen Tobi Johnson | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Nov 2025 | 143,373 | 0 (0%) | 0% | - | Common Stock | |
| Lincoln National Corp | Ellen G. Cooper | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 38,891 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Lincoln National Corp | Ellen G. Cooper | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.50 per share. | 26 Nov 2025 | 38,891 | 583,644 (0%) | 0% | 35.5 | 1,380,631 | Common Stock |
| Lincoln National Corp | Ellen G. Cooper | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.35 per share. | 26 Nov 2025 | 35,726 | 547,918 (0%) | 0% | 41.3 | 1,477,270 | Common Stock |
| Premier Inc (Class A) | Ellen C. Wolf | Director | Sale or transfer of securities back to the company at price $ 28.25 per share. | 25 Nov 2025 | 51,938 | 0 (0%) | 0% | 28.3 | 1,467,249 | Class A Common Stock |
| Mesa Air Grp Inc | Ellen N. Artist | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2025 | 1,483 | 10,782 | - | 0 | Common Stock | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 24 Nov 2025 | 36,000 | 507,710 (0%) | 0% | 10 | 360,000 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.13 per share. | 24 Nov 2025 | 36,000 | 543,710 (0%) | 0% | 5.1 | 184,680 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.06 per share. | 24 Nov 2025 | 36,000 | 507,710 (0%) | 0% | 10.1 | 362,268 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 36,000 | 23,621 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 25,000 | 0 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.10 per share. | 24 Nov 2025 | 25,000 | 532,710 (0%) | 0% | 6.1 | 152,500 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 23,621 | 0 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 24 Nov 2025 | 23,621 | 507,710 (0%) | 0% | 10 | 236,210 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.13 per share. | 24 Nov 2025 | 23,621 | 531,331 (0%) | 0% | 5.1 | 121,176 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.13 per share. | 24 Nov 2025 | 11,000 | 543,710 (0%) | 0% | 5.1 | 56,430 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 11,000 | 59,621 | - | - | Stock Options (right to buy) | |
| Lincoln National Corp | Ellen G. Cooper | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.34 per share. | 24 Nov 2025 | 4,401 | 544,753 (0%) | 0% | 40.3 | 177,536 | Common Stock |
| EZCorp Inc (Class A) | Ellen .H Bryant | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.82 per share. | 19 Nov 2025 | 53,622 | 188,889 (0%) | 0% | 17.8 | 955,544 | Class A Non-Voting Common Stock |
| EZCorp Inc (Class A) | Ellen .H Bryant | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 53,622 | 122,409 | - | - | Restricted Stock Units | |
| EZCorp Inc (Class A) | Ellen .H Bryant | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.82 per share. | 19 Nov 2025 | 21,103 | 167,786 (0%) | 0% | 17.8 | 376,055 | Class A Non-Voting Common Stock |
| EZCorp Inc (Class A) | Ellen .H Bryant | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 16,020 | 176,031 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Sale of securities on an exchange or to another person at price $ 5.80 per share. | 17 Nov 2025 | 80,745 | 2,083,961 | - | 5.8 | 468,321 | Class A Common Stock |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 17 Nov 2025 | 80,745 | 2,164,706 | - | 0.2 | 19,379 | Class A Common Stock |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 80,745 | 1,462,229 | - | - | Stock Option (Right to Buy) | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 70.47 per share. | 17 Nov 2025 | 15 | 29,869 (0%) | 0% | 70.5 | 1,057 | Dividend Equivalent Unit |
| Take-Two Interactive Software | Ellen F. Siminoff | Director | Sale of securities on an exchange or to another person at price $ 235.95 per share. | 14 Nov 2025 | 270 | 3,350 (0%) | 0% | 236.0 | 63,707 | Common Stock |
| Take-Two Interactive Software | Ellen F. Siminoff | Director | Sale of securities on an exchange or to another person at price $ 235.95 per share. | 14 Nov 2025 | 144 | 2,716 (0%) | 0% | 236.0 | 33,977 | Common Stock |
| Citizens & Northern Corp | Tracy Ellen Watkins | EXEC. VP | Other type of transaction at price $ 19.41 per share. | 14 Nov 2025 | 90 | 9,233 (0%) | 0% | 19.4 | 1,747 | Common Stock |
| Citizens & Northern Corp | Tracy Ellen Watkins | EXEC. VP | Other type of transaction at price $ 19.46 per share. | 14 Nov 2025 | 90 | 6,322 (0%) | 0% | 19.5 | 1,751 | Common Stock |
| Old National Bancorp | Ellen A. Rudnick | Director | Grant, award, or other acquisition of securities at price $ 20.79 per share. | 13 Nov 2025 | 4,810 | 67,516 (0%) | 0% | 20.8 | 100,000 | Common Stock |
| First Citizens Bancshares Inc (NC) (Class A) | Ellen R. Alemany | Director | Purchase of securities on an exchange or from another person at price $ 1000.00 per share. | 13 Nov 2025 | 300 | 300 | - | 1000 | 300,000 | Depositary Shares |
| EZCorp Inc (Class A) | Ellen .H Bryant | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 30,200 | 160,011 | - | - | Restricted Stock Units | |
| Sanfilippo (John B.) & Son Inc | Ellen Connelly Taaffe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 1,536 | 12,857 (0%) | 0% | 0 | Common Stock | |
| Norwegian Cruise Line | Zillah Ellen Byng-Thorne | Director | Purchase of securities on an exchange or from another person at price $ 18.11 per share. | 06 Nov 2025 | 29,008 | 66,017 (0%) | 0% | 18.1 | 525,335 | Common Stock |
| Boston Scientific | Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 98.28 per share. | 06 Nov 2025 | 12,891 | 24,134 (0%) | 0% | 98.3 | 1,266,978 | Common Stock |
| Boston Scientific | Ellen M. Zane | Director | Other type of transaction at price $ 0.00 per share. | 29 Oct 2025 | 12,891 | 37,025 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 101.13 per share. | 27 Oct 2025 | 9,990 | 27,035 (0%) | 0% | 101.1 | 1,010,301 | Common Stock |
| Boston Scientific | Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 102.24 per share. | 27 Oct 2025 | 2,901 | 24,134 (0%) | 0% | 102.2 | 296,599 | Common Stock |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 15 Oct 2025 | 80,745 | 2,164,706 | - | 0.2 | 19,379 | Class A Common Stock |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 80,745 | 1,542,974 | - | - | Stock Option (Right to Buy) | |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Sale of securities on an exchange or to another person at price $ 8.26 per share. | 15 Oct 2025 | 80,745 | 2,083,961 | - | 8.3 | 666,954 | Class A Common Stock |
| Dell | Ellen J. Kullman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 79,806 | 8,801 | - | - | Options to Acquire Class C Common Stock | |
| Dell | Ellen J. Kullman | Director | Sale of securities on an exchange or to another person at price $ 153.56 per share. | 15 Oct 2025 | 79,806 | 65,662 (0%) | 0% | 153.6 | 12,255,009 | Class C Common Stock |
| Dell | Ellen J. Kullman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.98 per share. | 15 Oct 2025 | 79,806 | 145,468 (0%) | 0% | 14.0 | 1,115,688 | Class C Common Stock |
| NextPlat Corp | Douglas S. Ellenoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 20,000 | 145,000 (119%) | 16% | 0 | Common Stock | |
| Take-Two Interactive Software | Ellen F. Siminoff | Director | Sale of securities on an exchange or to another person at price $ 259.42 per share. | 15 Oct 2025 | 268 | 3,620 (0%) | 0% | 259.4 | 69,525 | Common Stock |
| Take-Two Interactive Software | Ellen F. Siminoff | Director | Sale of securities on an exchange or to another person at price $ 259.42 per share. | 15 Oct 2025 | 143 | 2,860 (0%) | 0% | 259.4 | 37,097 | Common Stock |
| WEC Energy | Mary Ellen Stanek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2025 | 292 | 50,286 | - | - | Phantom Stock Units | |
| RPM Intl Inc | Ellen M. Pawlikowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 1,400 | 6,500 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Take-Two Interactive Software | Ellen F. Siminoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 1,064 | 8,255 (0%) | 0% | 0 | Common Stock | |
| J.Jill Inc | Mary Ellen Coyne | Director, CEO & President | Other type of transaction at price $ 0.00 per share. | 01 Oct 2025 | 782 | 165,131 (0%) | 0% | 0 | Common Stock | |
| Nexstar Media Grp Inc | Ellen Tobi Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 571 | 0 | - | - | Restricted Stock Units | |
| Nexstar Media Grp Inc | Ellen Tobi Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 571 | 571 (0%) | 0% | 0 | Common Stock | |
| J.Jill Inc | Mary Ellen Coyne | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 71 | 15,011 | - | - | Performance Stock Units | |
| Modular Medical Inc | Ellen Vos O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| Dell | Ellen J. Kullman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 1,587 | 65,662 (0%) | 0% | 0 | Class C Common Stock | |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 28.78 per share. | 30 Sep 2025 | 804 | 37,528 (0%) | 0% | 28.8 | 23,139 | Common Stock |
| Synchrony Financial | M. Zane Ellen | Director | Grant, award, or other acquisition of securities at price $ 71.05 per share. | 30 Sep 2025 | 775 | 29,854 (0%) | 0% | 71.1 | 55,064 | Common Stock |
| Merck & Company | Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 357 | 28,684 | - | - | Phantom Stock | |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director, Founder & Chief Innovation Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2025 | 80,745 | 1,623,719 | - | - | Stock Option (Right to Buy) | |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director, Founder & Chief Innovation Ofc | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 15 Sep 2025 | 80,745 | 2,083,961 | - | 8.5 | 683,103 | Class A Common Stock |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director, Founder & Chief Innovation Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 15 Sep 2025 | 80,745 | 2,164,706 | - | 0.2 | 19,379 | Class A Common Stock |
| Take-Two Interactive Software | Ellen Siminoff F. | Director | Sale of securities on an exchange or to another person at price $ 246.25 per share. | 15 Sep 2025 | 270 | 3,888 (0%) | 0% | 246.3 | 66,488 | Common Stock |